Wealth Enhancement Advisory Services’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.7K | Sell |
10,816
-16,000
| -60% | -$4K | ﹤0.01% | 3340 |
|
|
2025
Q1 | $5.28K | Hold |
26,816
| – | – | ﹤0.01% | 2923 |
|
|
2024
Q4 | $14.4K | Buy |
26,816
+16,000
| +148% | +$8.62K | ﹤0.01% | 2868 |
|
|
2024
Q3 | $10.3K | Sell |
10,816
-24,286
| -69% | -$23.1K | ﹤0.01% | 2633 |
|
|
2024
Q2 | $34.2K | Buy |
35,102
+2,863
| +9% | +$2.79K | ﹤0.01% | 2450 |
|
|
2024
Q1 | $50.9K | Hold |
32,239
| – | – | ﹤0.01% | 2329 |
|
|
2023
Q4 | $25.6K | Buy |
32,239
+2,000
| +7% | +$1.59K | ﹤0.01% | 2228 |
|
|
2023
Q3 | $23.6K | Buy |
+30,239
| New | +$23.6K | ﹤0.01% | 2156 |
|